| Parameter . | All SRV patients (N = 38) . | TGA post-atrial switch repair (N = 24) . | ccTGA (N = 14) . | P-value . |
|---|---|---|---|---|
| Age, years | 45 ± 12 | 42 ± 7.8 | 48 ± 16 | 0.128 |
| Gender (male) | 24 (63%) | 15 (63%) | 9 (64%) | 0.951 |
| BSA, m2 | 1.9 ± 0.22 | 1.9 ± 0.18 | 1.9 ± 0.27 | 0.385 |
| BMI, kg/m2 | 25 ± 3.4 | 25 ± 2.9 | 26 ± 4.2 | 0.526 |
| SBP, mmHg | 116 ± 17 | 116 ± 16 | 117 ± 22 | 0.843 |
| DBP, mmHg | 62 ± 12 | 59 ± 8 | 70 ± 17 | 0.024 |
| HR, bpm | 65 ± 11 | 62 ± 12 | 67 ± 11 | 0.203 |
| VSD | 4 (11%) | 3 (13%) | 1 (7%) | 0.570 |
| (Sub-)Pulmonary stenosis | 5 (13%) | 4 (17%) | 1 (7%) | 0.388 |
| Presence of implanted cardiac device | 16 (42%) | 7 (29%) | 9 (64%) | 0.037 |
| TVR | 2 (5%) | 0 | 2 (14%) | 0.063 |
| Tricuspid regurgitation | ||||
| No or trivial | 5 (13%) | 3 (13%) | 2 (14%) | |
| Mild | 8 (21%) | 6 (25%) | 2 (14%) | |
| Moderate | 20 (53%) | 13 (54%) | 7 (50%) | 0.537a |
| Severe | 5 (13%) | 2 (8%) | 3 (21%) | 0.253b |
| Systemic RV systolic function (visually) | ||||
| Normal | 5 (13%) | 2 (8%) | 3 (21%) | 0.253 |
| Reduced | 33 (87%) | 22 (92%) | 11 (79%) | |
| LV systolic function (visually) | ||||
| Normal | 30 (79%) | 18 (75%) | 12 (86%) | 0.428 |
| Reduced | 8 (21%) | 6 (25%) | 2 (14%) | |
| NYHA class | ||||
| 1–2 | 28 (74%) | 17 (71%) | 11 (79%) | 0.593 |
| 3–4 | 10 (26%) | 7 (29%) | 3 (21%) | |
| BNP, ng/L | 88 (64–315) | 88 (70–330) | 86 (45–353) | 0.567 |
| Parameter . | All SRV patients (N = 38) . | TGA post-atrial switch repair (N = 24) . | ccTGA (N = 14) . | P-value . |
|---|---|---|---|---|
| Age, years | 45 ± 12 | 42 ± 7.8 | 48 ± 16 | 0.128 |
| Gender (male) | 24 (63%) | 15 (63%) | 9 (64%) | 0.951 |
| BSA, m2 | 1.9 ± 0.22 | 1.9 ± 0.18 | 1.9 ± 0.27 | 0.385 |
| BMI, kg/m2 | 25 ± 3.4 | 25 ± 2.9 | 26 ± 4.2 | 0.526 |
| SBP, mmHg | 116 ± 17 | 116 ± 16 | 117 ± 22 | 0.843 |
| DBP, mmHg | 62 ± 12 | 59 ± 8 | 70 ± 17 | 0.024 |
| HR, bpm | 65 ± 11 | 62 ± 12 | 67 ± 11 | 0.203 |
| VSD | 4 (11%) | 3 (13%) | 1 (7%) | 0.570 |
| (Sub-)Pulmonary stenosis | 5 (13%) | 4 (17%) | 1 (7%) | 0.388 |
| Presence of implanted cardiac device | 16 (42%) | 7 (29%) | 9 (64%) | 0.037 |
| TVR | 2 (5%) | 0 | 2 (14%) | 0.063 |
| Tricuspid regurgitation | ||||
| No or trivial | 5 (13%) | 3 (13%) | 2 (14%) | |
| Mild | 8 (21%) | 6 (25%) | 2 (14%) | |
| Moderate | 20 (53%) | 13 (54%) | 7 (50%) | 0.537a |
| Severe | 5 (13%) | 2 (8%) | 3 (21%) | 0.253b |
| Systemic RV systolic function (visually) | ||||
| Normal | 5 (13%) | 2 (8%) | 3 (21%) | 0.253 |
| Reduced | 33 (87%) | 22 (92%) | 11 (79%) | |
| LV systolic function (visually) | ||||
| Normal | 30 (79%) | 18 (75%) | 12 (86%) | 0.428 |
| Reduced | 8 (21%) | 6 (25%) | 2 (14%) | |
| NYHA class | ||||
| 1–2 | 28 (74%) | 17 (71%) | 11 (79%) | 0.593 |
| 3–4 | 10 (26%) | 7 (29%) | 3 (21%) | |
| BNP, ng/L | 88 (64–315) | 88 (70–330) | 86 (45–353) | 0.567 |
Data are presented as mean ± SD or n (%); BNP is presented as median (interquartile range).
P-value indicates difference between TGA and ccTGA subgroups.
BMI, body mass index; BSA, body surface area; DBP, diastolic blood pressure; HR, heart rate; SBP, systolic blood pressure; TVR, tricuspid valve replacement; VSD, ventricular septal defect.
For no/trivial/mild vs. moderate/severe tricuspid regurgitation.
For no/trivial/mild/moderate vs. severe tricuspid regurgitation.
| Parameter . | All SRV patients (N = 38) . | TGA post-atrial switch repair (N = 24) . | ccTGA (N = 14) . | P-value . |
|---|---|---|---|---|
| Age, years | 45 ± 12 | 42 ± 7.8 | 48 ± 16 | 0.128 |
| Gender (male) | 24 (63%) | 15 (63%) | 9 (64%) | 0.951 |
| BSA, m2 | 1.9 ± 0.22 | 1.9 ± 0.18 | 1.9 ± 0.27 | 0.385 |
| BMI, kg/m2 | 25 ± 3.4 | 25 ± 2.9 | 26 ± 4.2 | 0.526 |
| SBP, mmHg | 116 ± 17 | 116 ± 16 | 117 ± 22 | 0.843 |
| DBP, mmHg | 62 ± 12 | 59 ± 8 | 70 ± 17 | 0.024 |
| HR, bpm | 65 ± 11 | 62 ± 12 | 67 ± 11 | 0.203 |
| VSD | 4 (11%) | 3 (13%) | 1 (7%) | 0.570 |
| (Sub-)Pulmonary stenosis | 5 (13%) | 4 (17%) | 1 (7%) | 0.388 |
| Presence of implanted cardiac device | 16 (42%) | 7 (29%) | 9 (64%) | 0.037 |
| TVR | 2 (5%) | 0 | 2 (14%) | 0.063 |
| Tricuspid regurgitation | ||||
| No or trivial | 5 (13%) | 3 (13%) | 2 (14%) | |
| Mild | 8 (21%) | 6 (25%) | 2 (14%) | |
| Moderate | 20 (53%) | 13 (54%) | 7 (50%) | 0.537a |
| Severe | 5 (13%) | 2 (8%) | 3 (21%) | 0.253b |
| Systemic RV systolic function (visually) | ||||
| Normal | 5 (13%) | 2 (8%) | 3 (21%) | 0.253 |
| Reduced | 33 (87%) | 22 (92%) | 11 (79%) | |
| LV systolic function (visually) | ||||
| Normal | 30 (79%) | 18 (75%) | 12 (86%) | 0.428 |
| Reduced | 8 (21%) | 6 (25%) | 2 (14%) | |
| NYHA class | ||||
| 1–2 | 28 (74%) | 17 (71%) | 11 (79%) | 0.593 |
| 3–4 | 10 (26%) | 7 (29%) | 3 (21%) | |
| BNP, ng/L | 88 (64–315) | 88 (70–330) | 86 (45–353) | 0.567 |
| Parameter . | All SRV patients (N = 38) . | TGA post-atrial switch repair (N = 24) . | ccTGA (N = 14) . | P-value . |
|---|---|---|---|---|
| Age, years | 45 ± 12 | 42 ± 7.8 | 48 ± 16 | 0.128 |
| Gender (male) | 24 (63%) | 15 (63%) | 9 (64%) | 0.951 |
| BSA, m2 | 1.9 ± 0.22 | 1.9 ± 0.18 | 1.9 ± 0.27 | 0.385 |
| BMI, kg/m2 | 25 ± 3.4 | 25 ± 2.9 | 26 ± 4.2 | 0.526 |
| SBP, mmHg | 116 ± 17 | 116 ± 16 | 117 ± 22 | 0.843 |
| DBP, mmHg | 62 ± 12 | 59 ± 8 | 70 ± 17 | 0.024 |
| HR, bpm | 65 ± 11 | 62 ± 12 | 67 ± 11 | 0.203 |
| VSD | 4 (11%) | 3 (13%) | 1 (7%) | 0.570 |
| (Sub-)Pulmonary stenosis | 5 (13%) | 4 (17%) | 1 (7%) | 0.388 |
| Presence of implanted cardiac device | 16 (42%) | 7 (29%) | 9 (64%) | 0.037 |
| TVR | 2 (5%) | 0 | 2 (14%) | 0.063 |
| Tricuspid regurgitation | ||||
| No or trivial | 5 (13%) | 3 (13%) | 2 (14%) | |
| Mild | 8 (21%) | 6 (25%) | 2 (14%) | |
| Moderate | 20 (53%) | 13 (54%) | 7 (50%) | 0.537a |
| Severe | 5 (13%) | 2 (8%) | 3 (21%) | 0.253b |
| Systemic RV systolic function (visually) | ||||
| Normal | 5 (13%) | 2 (8%) | 3 (21%) | 0.253 |
| Reduced | 33 (87%) | 22 (92%) | 11 (79%) | |
| LV systolic function (visually) | ||||
| Normal | 30 (79%) | 18 (75%) | 12 (86%) | 0.428 |
| Reduced | 8 (21%) | 6 (25%) | 2 (14%) | |
| NYHA class | ||||
| 1–2 | 28 (74%) | 17 (71%) | 11 (79%) | 0.593 |
| 3–4 | 10 (26%) | 7 (29%) | 3 (21%) | |
| BNP, ng/L | 88 (64–315) | 88 (70–330) | 86 (45–353) | 0.567 |
Data are presented as mean ± SD or n (%); BNP is presented as median (interquartile range).
P-value indicates difference between TGA and ccTGA subgroups.
BMI, body mass index; BSA, body surface area; DBP, diastolic blood pressure; HR, heart rate; SBP, systolic blood pressure; TVR, tricuspid valve replacement; VSD, ventricular septal defect.
For no/trivial/mild vs. moderate/severe tricuspid regurgitation.
For no/trivial/mild/moderate vs. severe tricuspid regurgitation.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
